| Waters Edge Healthcare & Rehab | |
| 512 Union Street, Trenton, New Jersey 08611 | |
| (609) 393-8622 | |
| Name | Waters Edge Healthcare & Rehab |
|---|---|
| Location | 512 Union Street, Trenton, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 215 |
| Occupancy Rate | 50.09% |
| Medicare ID (CCN) | 315324 |
| Legal Business Name | Llmd Associates Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1487641767 |
| Organization Name | LLMD ASSOCIATES LLC |
| Doing Business As | WATERSEDGE HEALTHCARE & REHABILATAION CENTER |
| Address | 512 Union St, Trenton, NJ 08611 |
| Phone Number | 609-393-8622 |
News Archive
"[T]he United States has announced an additional $51 million in humanitarian aid to the people of the Sahel - a belt up to 1,000 kilometers wide that spans Africa from the Atlantic Ocean to the Red Sea - bringing its total aid to $520 million" in FY 2012, Devex's "Pennsylvania Ave." blog reports.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase I study of CPSI-2364, its orally active, small-molecule inhibitor of the production of TNF-alpha and other pro-inflammatory cytokines.
A new procedure for the imaging of coronary veins proves to be "less invasive, have less complications, and improves the quality of diagnosis and treatment " for individuals undergoing surgical procedures on the heart and particularly the coronary veins, a recent study found.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
"[T]he United States has announced an additional $51 million in humanitarian aid to the people of the Sahel - a belt up to 1,000 kilometers wide that spans Africa from the Atlantic Ocean to the Red Sea - bringing its total aid to $520 million" in FY 2012, Devex's "Pennsylvania Ave." blog reports.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase I study of CPSI-2364, its orally active, small-molecule inhibitor of the production of TNF-alpha and other pro-inflammatory cytokines.
A new procedure for the imaging of coronary veins proves to be "less invasive, have less complications, and improves the quality of diagnosis and treatment " for individuals undergoing surgical procedures on the heart and particularly the coronary veins, a recent study found.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.21 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.6 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 24 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.27 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.54 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.89 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.91 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.82 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.42 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16.17 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.66 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.97 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 98.11 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 94.14 | 82.93 |
News Archive
"[T]he United States has announced an additional $51 million in humanitarian aid to the people of the Sahel - a belt up to 1,000 kilometers wide that spans Africa from the Atlantic Ocean to the Red Sea - bringing its total aid to $520 million" in FY 2012, Devex's "Pennsylvania Ave." blog reports.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase I study of CPSI-2364, its orally active, small-molecule inhibitor of the production of TNF-alpha and other pro-inflammatory cytokines.
A new procedure for the imaging of coronary veins proves to be "less invasive, have less complications, and improves the quality of diagnosis and treatment " for individuals undergoing surgical procedures on the heart and particularly the coronary veins, a recent study found.
› Verified 8 days ago
Providence Nursing And Rehabilitation Center Location: 439 Bellevue Avenue, Trenton, New Jersey 08618 Phone: (609) 396-2646 | |
Greenwood House Home For The Jewish Aged Location: 53 Walter Street, Trenton, New Jersey 08628 Phone: (609) 883-5391 | |
Riverside Nursing And Rehabilitation Center Location: 325 Jersey Street, Trenton, New Jersey 08611 Phone: (609) 394-3400 | |
Waters Edge Healthcare & Rehab Location: 512 Union Street, Trenton, New Jersey 08611 Phone: (609) 393-8622 | |
Royal Health Gate Nrsg Rehab Location: 1314 Brunswick Avenue, Trenton, New Jersey 08638 Phone: (609) 656-9291 |